Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew text states that publications are provided voluntarily by the person entering study information and that some publications are automatically filled from PubMed. The revision version is updated to v3.3.2.SummaryDifference0.3%

- Check28 days agoChange DetectedThe government funding/operating status notice was removed from the page. Core study details and links remain unchanged.SummaryDifference0.1%

- Check42 days agoChange DetectedThe Study Details page appears unchanged between the screenshots; there are no new locations, eligibility criteria, or outcomes visible. The differences seem limited to minor UI elements.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check92 days agoChange DetectedUpdated the page to revision v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed; no other substantive changes to core content, pricing, stock, or time-sensitive information.SummaryDifference0.1%

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.